More than 95,000 people in the U.S. die of alcohol-related causes each year, reports the Centers for Disease Control and Prevention. That number is likely underestimated, suggests Joe Zein, MD, PhD, MBA, a pulmonologist in Cleveland Clinic’s Respiratory Institute.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“We know the direct impact of alcohol use disorder, but we don’t know the indirect impact on other diseases,” he says. “Excessive alcohol use can cause liver failure. It can blunt immune response and lead to malnutrition. But how does it affect outcomes in asthma, for example? The indirect burden of alcohol and substance use is equally important to our healthcare system and to society.”
A study recently published in Alcohol explored the relationship.
Dr. Zein and a research team analyzed the records of more than 2 million patients with asthma or chronic obstructive pulmonary disease (COPD) in the Nationwide Emergency Department Sample and 1.1 million in the 2012-2015 Nationwide Readmissions Database. They found that patients with alcohol use disorder were more likely to:
“These findings really weren’t surprising,” says Dr. Zein. “The effects of alcohol, which can include higher risk of aspiration, infection and muscle wasting, can affect respiratory function and endurance, making respiratory failure more likely.”
The study is the first to draw the distinct correlation between alcohol use disorder and adverse outcomes in asthma and COPD. It echoes the research team’s 2020 study, published in the Journal of Asthma, which linked illegal drug use in the same cohort with higher healthcare use and cost.
“The increase in disease morbidity persists even after adjusting for the effects of alcohol or substance misuse and related comorbidities,” says Dr. Zein.
This study may prompt more pulmonologists to ask about alcohol use and illicit drug use when managing patients with asthma or COPD, and potentially other respiratory diseases.
Alcohol use isn’t an issue only for primary care, emphasizes Dr. Zein. If a primary care provider has already discussed reducing alcohol for the patient’s overall health, a pulmonologist can encourage reducing alcohol specifically to decrease the burden of respiratory disease.
“We’ve been focused on reducing the cost and burden of asthma and COPD with better medication, better education and better follow-ups,” he says. “Now we have another method: treating alcohol use disorder.”
A review of conservative, pressure-based and surgical treatments for OSA
Volatile organic compounds have potential in heart failure diagnostics
Insights for diagnosing, assessing and treating
Two NIH grants are looking at developing new antidotes against fentanyl overdose
Exploring the responses to medications and other supportive therapies
A set of graphs helps quantify the expected changes in forced expiratory volume at one second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio with the new race-neutral equation
Because of the associated symptoms, a multidisciplinary approach to care is essential
Patients with COPD are often affected by sarcopenia, but the underlying mechanisms for the development are poorly understood. New research looks into the causes and potential therapies
